Alyeska Investment Group
ALPN

Alyeska Investment Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Alyeska Investment Group’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,551
Closed -$571K – 567
2016
Q3 		$571K Buy
17,551
+699
+4% +$17K 0.01% 427
2016
Q2 		$310K Buy
16,852
+342
+2% +$6.07K ﹤0.01% 412
2016
Q1 		$275K Buy
16,510
+3,841
+30% +$76.9K ﹤0.01% 374
2015
Q4 		$392K Buy
12,669
+417
+3% +$14.2K ﹤0.01% 359
2015
Q3 		$636K Buy
12,252
+6,002
+96% +$394K 0.01% 412
2015
Q2 		$379K Buy
+6,250
New +$372K ﹤0.01% 465

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's ALPN Position: Q4 2016 in Review

Alyeska Investment Group sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2016, closing a stake of 17,551 shares — an estimated $571K sold.

Alyeska Investment Group first reported a position in ALPN in Q2 2015 and held it in 6 quarters. The position peaked at $636K in Q3 2015. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

  • Alyeska Investment Group reported no remaining Alpine Immune Sciences Inc position as of Q4 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 17,551 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $571K.
  • Alyeska Investment Group first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 6 quarters.
  • Alyeska Investment Group's Alpine Immune Sciences Inc position peaked at $636K in Q3 2015.
  • 38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on Alyeska Investment Group's 13F filing for Q4 2016, filed 14 Feb 2017.